Artemis Medicare Services Limited

Web: artemishospitals.com NSE: ARTEMISMED BSE: 542919 SECTOR: Healthcare - Healthcare Services | Add Note | View Notes

304 2(1%)

Volume

2L as on 23, Jun

Open

317

High

327

Low

313

301

VWAP

270

52 Week High

379

52 Week Low

203

Viand Research Rating

Quality Score

66/100

Growth Score

48/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

4,805

No. of Shares

15.8

P/E

70.24

P/B

10.1

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

14.37

ROCE

Profit Growth

Listing Date

23-Jan-20

Rank/Sector Rank

#831/#78

Promoter Holding

58.39%

FII Holding

12.28%

DII Holding

2.4%

Price Chart

Price Performance

1 Week2%

1 Month2%

3 Months22%

6 Months16%

1 Year16%

YTD16%

Moving Average

5 Day SMA263

10 Day SMA262

20 Day SMA266

30 Day SMA269

50 Day SMA259

61 Day SMA252

80 Day SMA295

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	295	273	286	295
Resistance 2	286	272	279	286
Resistance 1	277	270	275	277
Pivot Point	268	268	268	268
Support 1	259	267	261	259
Support 2	250	265	257	250
Support 3	241	263	250	241

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,18,698	1745	0%	5%	4%	4%	37	55.5	0.07	11509
2	DIVISLAB	2,43,966	9190	2%	0%	45%	38%	69	55.5	0	2568
3	TORNTPHARM	1,73,208	4554	2%	5%	10%	28%	72	55.5	1.79	2138
4	ZYDUSLIFE	1,11,451	1117	0%	1%	20%	12%	20	55.5	0.31	3560
5	APOLLOHOSP	1,09,276	7600	2%	9%	4%	1%	58	55.5	0.9	2003
6	LAURUSLABS	1,08,738	2012	1%	8%	83%	124%	0	55.5	0.48	890
7	CIPLA	1,06,154	1314	2%	2%	8%	19%	22	55.5	0.02	3862
8	DRREDDY	1,03,873	1244	3%	8%	1%	4%	20	55.5	0.2	4158
9	MANKIND	94,401	2286	4%	1%	8%	7%	49	55.5	0.39	1938
10	AUROPHARMA	90,841	1579	2%	1%	20%	52%	0	55.5	0.19	2415
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 58.39%	(0.01) 58.39%	(-8.21) 58.38%	(0.01) 66.53%	(-0.61) 66.53%	(0.01) 67.17%	(0.01) 67.17%	(-0.31) 67.17%	(-0.51) 67.51%	(0.01) 68.03%	(0.01) 68.03%	(0.01) 68.03%	(-0.91) 68.03%	(0.01) 68.91%	(-0.41) 68.91%	(-0.31) 69.27%	(-0.21) 69.59%	(0.01) 69.82%	(0.01) 69.82%	(0.01) 69.82%
FIIs	(0.11) 12.28%	(-0.31) 12.19%	(12.11) 12.47%	(0.11) 0.37%	(-0.11) 0.24%	(-0.31) 0.31%	(0.41) 0.65%	(0.11) 0.21%	(0.11) 0.16%	(0.01) 0.10%	(0.01) 0.11%	(0.01) 0.09%	(0.11) 0.07%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(-0.51) 2.40%	(0.01) 2.89%	(-1.41) 2.91%	(-0.51) 4.27%	(-0.31) 4.76%	(0.51) 5.04%	(0.91) 4.51%	(0.21) 3.60%	(0.81) 3.45%	(0.71) 2.61%	(0.51) 1.96%	(0.11) 1.51%	(0.01) 1.41%	(0.21) 1.37%	(0.31) 1.15%	(0.01) 0.90%	(-0.21) 0.91%	(-0.11) 1.10%	(0.01) 1.22%	(0.01) 1.22%
Government	6.16%	6.16%	6.16%	7.02%	7.02%	7.09%	7.09%	7.09%	7.12%	7.18%	7.18%	7.18%	7.18%	7.27%	7.27%	7.31%	7.34%	7.37%	7.37%	7.37%
Public	20.76%	20.37%	20.07%	21.81%	21.45%	20.39%	20.59%	21.93%	21.76%	22.08%	22.72%	23.18%	23.30%	22.43%	22.65%	22.53%	22.17%	21.71%	21.59%	21.59%
No. of Shareholders	36,335	32,044	31,602	33,559	31,614	28,397	27,004	26,054	19,795	19,993	22,375	20,529	19,082	18,100	17,995	14,637	15,177	12,098	12,827	10,765

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	287	279	272	275	255	240	232	241	223	225	219	225	210	195	187	187	167	149	144	139	122
Sales Growth % (YoY)	12.7%	16.4%	17.2%	13.8%	14.2%	6.5%	6.2%	7.3%	6.5%	15.3%	16.7%	20%	25.3%	30.7%	30.1%	34.8%	36.8%	15.7%	16%	50.6%	95%
Sales Growth % (QoQ)	2.9%	2.6%	-1.1%	7.8%	6.2%	3.4%	-3.7%	8.1%	-0.9%	2.7%	-2.7%	7.1%	7.7%	4.3%	-	12%	12.1%	3.5%	3.6%	13.9%	-
Expenses	231	228	228	224	214	204	195	199	187	187	186	191	182	170	162	164	148	132	126	119	109
Operating Profit	56	52	45	51	41	36	37	42	36	38	33	34	28	26	26	23	19	17	18	20	13
OPM %	20	18	16	18	16	15	16	18	16	17	15	15	13	13	14	13	11	11	12	14	11
Other Income	5	8	4	8	7	12	9	7	4	2	2	2	1	2	1	1	2	1	1	1	1
Interest	6	6	7	7	7	8	8	8	8	9	8	8	7	5	5	5	4	4	3	3	2
Depreciation	13	13	12	12	11	12	11	11	11	11	10	10	9	9	8	7	7	6	6	5	5
Profit before tax	43	40	30	39	30	29	27	31	22	20	16	19	13	14	13	13	11	8	10	13	6
Tax %	26	25	25	24	29	20	23	28	24	29	29	28	26	24	23	31	22	-61	36	36	41
Net Profit	31	30	22	30	21	23	21	22	17	14	12	14	10	11	10	9	8	13	6	8	4
Net Profit Growth % (QoQ)	3.3%	36.4%	-26.7%	42.9%	-8.7%	9.5%	-4.5%	29.4%	21.4%	16.7%	-14.3%	40%	-9.1%	10%	11.1%	12.5%	-38.5%	116.7%	-25%	100%	-
Net Profit Growth % (YoY)	47.6%	30.4%	4.8%	36.4%	23.5%	64.3%	75%	57.1%	70%	27.3%	20%	55.6%	25%	-15.4%	66.7%	12.5%	100%	-	-	-	-
TTM Net Profit	113	103	96	95	87	83	74	65	57	50	47	45	40	38	40	36	35	31	18	12	0
EPS in Rs	1.98	1.9	1.41	2.16	1.53	1.67	1.5	1.62	1.22	1.04	0.85	1	0.72	0.79	0.78	0.68	0.63	1	0.49	0.62	0.29

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Sales	1081	937	879	737	555	408	565	547
Sales Growth %	15.4%	6.6%	19.1%	32.9%	35.8%	-27.7%	3.4%	-
Expenses	893	785	746	643	487	373	503	481
Operating Profit	188	152	133	94	68	35	62	66
OPM %	17	16	15	13	12	9	11	12
Other Income	27	33	7	7	3	7	4	2
Interest	28	32	31	20	12	13	13	11
Depreciation	48	45	40	31	22	22	23	20
Profit before tax	139	108	68	51	37	8	31	37
Tax %	25	24	28	25	16	18	36	45
Net Profit	104	82	49	38	31	6	19	20
Net Profit Growth %	26.8%	67.3%	28.9%	22.6%	416.7%	-68.4%	-5%	-
EPS in Rs	6.55	6	3.62	2.88	2.4	0.49	1.49	0.97
Dividend Payout %	7	7	12	16	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash from Operating Activity	132	156	109	127	60	27	56	40
Cash from Investing Activity	-90	-393	-88	-158	-107	-37	-26	-50
Cash from Financing Activity	-50	264	-29	38	44	18	-27	14
Net Cash Flow	-8	27	-8	7	-3	8	2	5

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Equity Capital	16	14	14	14	14	13	13	13	13	13
Reserves	919	869	824	779	435	390	346	307	300	280
Borrowings	262	279	290	320	320	286	201	147	113	114
Other Liabilities	232	264	229	226	203	216	149	133	160	147
Total Liabilities	1429	1426	1357	1339	972	905	710	600	586	554
Fixed Assets	804	794	745	735	719	605	489	383	393	381
CWIP	29	35	40	44	33	95	64	81	56	49
Investments	0	0	0	0	0	0	0	0	0	0
Other Assets	596	597	572	561	219	205	157	136	137	124
Total Assets	1429	1426	1357	1339	972	905	710	600	586	554

Delivery

Delivery Data: ARTEMISMED

#	Date	292 30% 379	Value (Cr)	Q/T 39	Del 35	Del 29
1	21-Oct	302	9	15	59	5
2	19-Oct	301	3	15	60	2
3	16-Oct	306	4	14	52	2
4	15-Oct	303	4	11	56	2
5	14-Oct	302	7	18	58	4
6	13-Oct	311	4	13	52	2
7	12-Oct	311	5	14	51	3
8	9-Oct	313	7	16	47	3
9	8-Oct	308	11	18	53	6
10	7-Oct	318	8	14	52	4
11	6-Oct	318	14	21	50	7
12	5-Oct	324	12	19	51	6
13	1-Oct	336	27	24	50	13
14	30-Sep	346	35	30	45	16
15	29-Sep	367	19	25	41	8
16	28-Sep	366	76	40	22	17
17	25-Sep	358	693	67	8	57
18	24-Sep	333	7	27	50	4
19	23-Sep	342	5	24	55	3
20	22-Sep	341	9	22	40	4
21	21-Sep	339	12	21	47	5
22	18-Sep	338	11	30	43	5
23	17-Sep	331	9	21	43	4
24	16-Sep	325	17	23	46	8
25	15-Sep	331	13	26	53	7
26	11-Sep	345	12	18	41	5
27	10-Sep	349	26	26	37	10
28	9-Sep	354	28	38	48	14
29	8-Sep	342	16	26	45	7
30	7-Sep	344	27	29	46	12
31	4-Sep	333	30	38	40	12
32	3-Sep	320	3	20	53	2
33	2-Sep	321	7	23	54	4
34	1-Sep	328	18	28	40	7
35	31-Aug	317	4	21	60	2
36	28-Aug	319	4	21	53	2
37	27-Aug	317	7	25	52	4
38	26-Aug	324	5	25	48	2
39	25-Aug	324	6	26	50	3
40	24-Aug	329	15	29	50	7
41	21-Aug	326	32	41	44	14
42	20-Aug	321	22	48	44	10
43	19-Aug	314	6	35	54	3
44	18-Aug	312	7	43	54	4
45	17-Aug	314	7	35	62	4
46	14-Aug	315	5	28	54	3
47	13-Aug	318	28	26	34	10

Daily Market Cap

Date	Total Market Cap	Change	Chg %
21-Oct	4,805c	29c	0.61
19-Oct	4,776c	59c	1.23
17-Oct	4,835c	0	0
16-Oct	4,835c	36c	0.74
15-Oct	4,800c	21c	0.44
14-Oct	4,821c	107c	2.17
13-Oct	4,928c	14c	0.27
12-Oct	4,914c	14c	0.27
09-Oct	4,928c	38c	0.78
08-Oct	4,890c	153c	3.03
06-Oct	5,043c	180c	3.45
05-Oct	5,223c	199c	3.66
01-Oct	5,422c	357c	6.18
29-Sep	5,779c	46c	0.79
28-Sep	5,825c	16c	0.27
25-Sep	5,809c	461c	8.63
24-Sep	5,347c	8c	0.15
22-Sep	5,355c	78c	1.47
17-Sep	5,278c	238c	4.32
10-Sep	5,516c	162c	3.03
07-Sep	5,354c	0	0

Stock Checklist

Price is above from 52 week high low average: 57%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 14 fund scheme(s) across 6 fund house(s) as of Oct26 · Total value ₹128 Cr · 4 increasing / 4 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
HSBC Mutual Fund	2	2.47%	+0.32%	86.4
Bandhan Mutual Fund	4	0.04%	-0.02%	30.2
JM Financial Mutual Fund	2	1.67%	+0.41%	8
LIC Mutual Fund	2	1.26%	-1.62%	2.5
Franklin Templeton Mutual Fund	2	0.00%	-	0.4
Motilal Oswal Mutual Fund	2	0.02%	-	0

Artemis Medicare Services Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements